|
|
Volumn 15, Issue 3, 2001, Pages 327-331
|
|
Embryotoxicity of meglumine antimoniate in the rat
|
|
Author keywords
Adverse effects; Anomalies; Antimony; Embryotoxicity; Leishmaniasis; Meglumine antimoniate; Pregnancy; Teratogenicity
|
|
Indexed keywords
ANTIPROTOZOAL AGENT;
MEGLUMINE;
MEGLUMINE ANTIMONATE;
ORGANOMETALLIC COMPOUND;
SODIUM CHLORIDE;
TERATOGENIC AGENT;
ANIMAL;
ANIMAL EXPERIMENT;
ARTICLE;
ATLAS;
BONE MALFORMATION;
CONGENITAL MALFORMATION;
CONTROLLED STUDY;
DRUG SAFETY;
EMBRYO;
EMBRYOTOXICITY;
FEMALE;
FETOTOXICITY;
FETUS DEATH;
FETUS WEIGHT;
GERMFREE ANIMAL;
LEISHMANIASIS;
MALE;
NONHUMAN;
PREGNANCY;
PRENATAL EXPOSURE;
RAT;
RAT STRAIN;
SUBCUTANEOUS DRUG ADMINISTRATION;
TERATOGENICITY;
TOXICITY TESTING;
ABNORMALITIES, DRUG-INDUCED;
ANIMALS;
ANTIPROTOZOAL AGENTS;
ATLAS;
EMBRYO;
FEMALE;
FETAL DEATH;
FETAL WEIGHT;
INJECTIONS, SUBCUTANEOUS;
MALE;
MEGLUMINE;
ORGANOMETALLIC COMPOUNDS;
PREGNANCY;
RATS;
RATS, WISTAR;
SPECIFIC PATHOGEN-FREE ORGANISMS;
TERATOGENS;
TOXICITY TESTS;
RATTUS NORVEGICUS;
|
|
EID: 0034968733
PISSN: 08906238
EISSN: None
Source Type: Journal
DOI: 10.1016/S0890-6238(01)00127-7 Document Type: Article |
|
Times cited : (20)
|
|
References (13)
|
